Cargando...

Gender-based differences in brain and plasma pharmacokinetics of letrozole in sprague-dawley rats: Application of physiologically-based pharmacokinetic modeling to gain quantitative insights

Based on the discovery that the estrogen synthase aromatase (CYP19A1) is abundantly expressed in high- grade gliomas, the aromatase inhibitor, letrozole is being investigated in pre-clinical models as a novel agent against this malignancy. Here, we investigated the systemic and brain pharmacokinetic...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Arora, Priyanka, Gudelsky, Gary, Desai, Pankaj B.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018653/
https://ncbi.nlm.nih.gov/pubmed/33798227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0248579
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!